Member Info for BuenaVista

Thanks. I thought it likely wouldn't be free!

@B2HS2L, could you give me the link to the PL broker note please?

Thanks B2HS2L. With that and the company's emphasis on SGC and TNBC I think it must be those two.

B2HS2L wrote " "We are also delighted to see initial signs of efficacy in both phase 1b indications".... (- implying TNBC & SGC)..."

This was our assumption at the time but is it not the case that the patients in the TNBC cohort had to go through an additional assessment (can't remember quite where that was stated nor what it was, but it definitely was stated) and so, starting a bit later than the other two cohort, the 'both' may refer to SGC and STS? As ever, the lack of clarity from the company over what should be made clear is frustrating.

Is that predicated on the principle that if a glass of red is good for you a couple of bottles are even better?

Well I didn't say they wanted a lower entry point for themselves...

- - - Do not feed the trolls - - -

Don't waste your time and energy engaging with their disinformation. They're not interested in learning, only in spreading fear, uncertainty and doubt (FUD) to take the share price down for a lower entry point.

If Avacta wasn't a good long-term investment they wouldn't be here would they...

Over 3 years in IND-enabling unfortunately.

"LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme": https://avacta.com/lg-chem-renews-license-triggering-payment-to-avacta/

An IND submission would surely trigger another milestone payment. Long overdue!!!

Avacta patents for 'Serum half-life extended pd-l1 binding polypeptides ':

https://patents.google.com/patent/WO2022023538A2/en

https://patents.google.com/patent/WO2023057946A1/en

Eggy's out again. Whether he's playing the fool with his 'concerns' and distortions or is just dim, it's a toss up and frankly I don't care.

What we do know is that the guy has no integrity and callously tries to manipulate others for his own advantage.

Best to bin or just call out as a troll, in which case "Don't feed the troll" is sufficient.

Earnings? Avacta don't have earnings! ...maybe interims?

3 September? Typo? 30 September, like last year?

Short was a buyer

The 200-day ma did start turning up a short while before the Golden Cross. It was a long flat bottom which is why it wasn't noticeable.

The RSI came down a bit yesterday but is still high at 73.62.

So, on a TA view, there is conflict between short-term share price correction or consolidation (RSI) and long-term rise (GC).

Https://www.lse.co.uk/news/AVCT/hvivo-appoints-avacta-chair-shaun-chilton-to-lead-board-l8llfueb7tkdvms.html

If you don't, just read through ToucanOfDoom's posting history.

HEMO was on an RSI of 95.38 yesterday and the share price is up another 25% or so today.

Due a correction in 5, 4, 3, ...

I've come across this Ade1234 character on the AFC Energy BB where he is one of the resident vermin and is loved as much as a fart in an elevator.

With this one you definitely need to hold your nose and ignore.

And the 'Spotlight' series of backgrounders: https://avacta.com/?s=spotlight

I would also recommend the company presentations on the website:

Presentations and Videos & General meeting documents: https://avacta.com/investors/investor-resources/

Conference posters: https://avacta.com/about/scientific-resources/

Myles McNulty has summarised the Avacta investment case. I don't have the link to the document to hand myself...

That's one of the conditions!